Table 1.
Characteristics of 99 HIV-1-infected children compared by study arm before initiating HAART
| Characteristic | Diary arm (n = 53) |
Control arm (n = 46) |
p-value | ||
|---|---|---|---|---|---|
| Median or No* | IQR or %** | Median or No* | IQR or %** | ||
| Age yrs | 4.1 | 2.0, 5.7 | 5.2 | 2.7, 6.9 | 0.15 |
| Males | 25* | 47** | 22* | 48** | 0.95 |
| Weight-for-age z-score |
-2.63 | -4.70,1.89 | -3.39 | -4.80, -1.92 | 0.52 |
| Height-for-age z-score |
-2.16 | -3.92, -1.60 | -2.27 | -3.54, -1.13 | 0.58 |
| Weight-for-height z-score | -1.37 | -2.81, -0.52 | -1.81 | -3.85, -0.81 | 0.27 |
| Log10 HIV-1 RNA copies/ml | 6.1 | 5.5, 6.5 | 5.9 | 5.4, 6.5 | 0.37 |
| CD4 count/μl | 340 | 138, 663 | 158 | 40, 474 | 0.02 |
| CD4 percent | 6.9 | 3.9, 13.8 | 5.5 | 2.0, 9.8 | 0.05 |
| NNRTI used | |||||
| Nevirapine | 35* | 66** | 26* | 56** | 0.33 |
| Efavirenz | 14* | 26** | 19* | 41** | 0.12 |
IQR: interquartile range
NNRTI: Non-nucleoside reverse transcriptase inhibitor